KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Equity (2016 - 2025)

Historic Return on Equity for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.14%.

  • Emergent BioSolutions' Return on Equity rose 6000.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 6000.0%. This contributed to the annual value of 0.34% for FY2024, which is 4100.0% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Return on Equity of 0.14% as of Q3 2025, which was up 6000.0% from 0.26% recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Return on Equity high stood at 0.26% for Q1 2021, and its period low was 1.13% during Q4 2023.
  • In the last 5 years, Emergent BioSolutions' Return on Equity had a median value of 0.15% in 2022 and averaged 0.26%.
  • Per our database at Business Quant, Emergent BioSolutions' Return on Equity plummeted by -9800bps in 2023 and then surged by 13700bps in 2025.
  • Emergent BioSolutions' Return on Equity (Quarter) stood at 0.14% in 2021, then crashed by -208bps to 0.15% in 2022, then tumbled by -644bps to 1.13% in 2023, then soared by 66bps to 0.38% in 2024, then soared by 135bps to 0.14% in 2025.
  • Its Return on Equity stands at 0.14% for Q3 2025, versus 0.26% for Q2 2025 and 0.25% for Q1 2025.